Extremely not long ago, preliminary results from a third demo evaluating ibrutinib compared to observation were presented.105 Sufferers getting ibrutinib experienced an extended occasion-totally free survival, but no In general survival gain, Even though the outcomes were nonetheless immature. Furthermore, Despite the fact that serious adverse func